(Q47364942)

14 January 2018

title

Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment (English)

1 reference

14 January 2018

0 references

0 references

1 reference

6

1 reference

14 January 2018

author name string

Robert W Stackman

1

1 reference

14 January 2018

Felix Eckenstein

2

1 reference

14 January 2018

Balz Frei

3

1 reference

14 January 2018

Doris Kulhanek

4

1 reference

14 January 2018

Jessica Nowlin

5

1 reference

14 January 2018

language of work or name

English

0 references

publication date

1 November 2003

1 reference

14 January 2018

published in

Experimental Neurology

1 reference

14 January 2018

volume

184

1 reference

14 January 2018

issue

1

1 reference

14 January 2018

page(s)

510-520

1 reference

14 January 2018

Up-regulation of the inflammatory cytokines IFN-gamma and IL-12 and down-regulation of IL-4 in cerebral cortex regions of APP(SWE) transgenic mice.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Oxidative modification of creatine kinase BB in Alzheimer's disease brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Effect of long-term treatment with EGb 761 on age-dependent structural changes in the hippocampi of three inbred mouse strains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Natural extracts as possible protective agents of brain aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Vitamin E protects nerve cells from amyloid beta protein toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Hydrogen peroxide mediates amyloid beta protein toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Neuroprotective effects of bilobalide, a component of the Ginkgo biloba extract (EGb 761), in gerbil global brain ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Effects of Ginkgo biloba extract (EGb 761) on learning and possible actions on aging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Oxidative stress, glutamate, and neurodegenerative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Characteristics of the in vitro vasoactivity of beta-amyloid peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Ginkgo biloba extract: mechanisms and clinical indications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Antioxidants, oxidative stress, and degenerative neurological disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

A short review of cognitive and functional neuroimaging studies of cholinergic drugs: implications for therapeutic potentials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Stable beta-secretase activity and presynaptic cholinergic markers during progressive central nervous system amyloidogenesis in Tg2576 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Transgenic mice expressing Alzheimer amyloid precursor proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Transgenic mouse models of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Differential, dose dependent changes in cognitive performance following acute administration of a Ginkgo biloba/Panax ginseng combination to healthy young volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Phospholipid breakdown and choline release under hypoxic conditions: inhibition by bilobalide, a constituent of Ginkgo biloba.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Effects of Ginkgetin from Ginkgo biloba Leaves on cyclooxygenases and in vivo skin inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Plaque-induced abnormalities in neurite geometry in transgenic models of Alzheimer disease: implications for neural system disruption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Genetically modified mice and cognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

The CNS effects of Ginkgo biloba extracts and ginkgolide B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

beta-Amyloid-induced toxicity in rat hippocampal cells: in vitro evidence for the involvement of free radicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Developments of a water-maze procedure for studying spatial learning in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Place navigation impaired in rats with hippocampal lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Can the cognitive enhancing effects of ginkgo biloba be explained by its pharmacology?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Oxidative damage is the earliest event in Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Myricetin and quercetin, the flavonoid constituents of Ginkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca(2+)-loaded brain neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Isoform-specific vasoconstriction induced by apolipoprotein E and modulation of this effect by Alzheimer's beta-amyloid peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Platelet-activating factor antagonists reduce excitotoxic damage in cultured neurons from embryonic chick telencephalon and protect the rat hippocampus and neocortex from ischemic injury in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Alzheimer's disease: genetic studies and transgenic models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Inhibition of age-induced beta-amyloid neurotoxicity in rat hippocampal cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Beta-amyloid plaques induce neuritic dystrophy of nitric oxide-producing neurons in a transgenic mouse model of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Memantine in moderate-to-severe Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

A Ginkgo biloba extract (EGb 761) prevents mitochondrial aging by protecting against oxidative stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Molecular, cellular, and neuroanatomical substrates of place learning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Amyloid-β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Ginkgo for memory enhancement: a randomized controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Small conductance Ca2+-activated K+ channels modulate synaptic plasticity and memory encoding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

The effects of melatonin and Ginkgo biloba extract on memory loss and choline acetyltransferase activities in the brain of rats infused intracerebroventricularly with beta-amyloid 1-40.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Early induction of interleukin-6 mRNA in the hippocampus and cortex of APPsw transgenic mice Tg2576.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

beta-Amyloid-mediated vasoactivity and vascular endothelial damage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Bilobalide, a constituent of Ginkgo biloba, inhibits NMDA-induced phospholipase A2 activation and phospholipid breakdown in rat hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Cholinergic strategies for Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Effects of an extract of Ginkgo biloba on learning and memory in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Facilitative effects of EGb 761 on olfactory recognition in young and aged rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Dissecting the behaviour of transgenic mice: is it the mutation, the genetic background, or the environment?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Protective effects of idebenone and alpha-tocopherol on beta-amyloid-(1-42)-induced learning and memory deficits in rats: implication of oxidative stress in beta-amyloid-induced neurotoxicity in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from beta-amyloid-induced cell death by inhibiting the formation of beta-amyloid-derived diffusible neurotoxic ligands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

Oxidative alterations in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Severity of spatial learning impairment in aging: development of a learning index for performance in the Morris water maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900399-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-4886(03)00399-6

1 reference

14 January 2018

1 reference

14 January 2018